Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

HNX:PMC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Cash & Equivalents	29,842	60,084	13,252	37,454	29,430	115,026
Short-Term Investments	112,000	141,000	249,000	256,100	242,131	111,500
Cash & Short-Term Investments	141,842	201,084	262,252	293,554	271,560	226,526
Cash Growth	-41.57%	-23.32%	-10.66%	8.10%	19.88%	33.47%
Accounts Receivable	30,004	41,222	39,310	35,254	39,175	34,034
Other Receivables	1,257	3,042	3,605	3,233	2,159	1,260
Receivables	31,260	44,264	42,915	38,487	41,335	35,294
Inventory	96,882	71,119	67,244	104,546	71,379	89,414
Prepaid Expenses	635.19	435.06	453.29	282.38	915.04	434.98
Other Current Assets	21,297	18,533	6,207	4,273	3,853	4,265
Total Current Assets	291,918	335,436	379,071	441,141	389,042	355,934
Property, Plant & Equipment	30,440	32,127	39,704	45,890	53,900	65,179
Other Intangible Assets	2,157	2,214	2,443	2,731	2,991	3,165
Other Long-Term Assets	8,440	6,062	5,157	4,362	5,560	4,774
Total Assets	332,955	375,839	426,375	494,124	451,494	429,053
Accounts Payable	28,199	16,250	12,730	15,668	8,378	12,575
Accrued Expenses	25,645	44,572	46,302	36,141	38,986	41,184
Current Income Taxes Payable	5,675	6,580	7,821	7,364	7,203	4,202
Current Unearned Revenue	1,479	1,457	1,002	669.46	804.02	733.99
Other Current Liabilities	17,719	17,369	15,322	6,500	7,246	6,184
Total Current Liabilities	78,717	86,227	83,178	66,342	62,617	64,879
Total Liabilities	78,717	86,227	83,178	66,342	62,617	64,879
Common Stock	93,326	93,326	93,326	93,326	93,326	93,326
Additional Paid-In Capital	972.97	972.97	972.97	972.97	972.97	972.97
Retained Earnings	159,940	195,313	248,898	333,483	294,578	269,875
Total Common Equity	254,238	289,612	343,197	427,782	388,877	364,173
Shareholders' Equity	254,238	289,612	343,197	427,782	388,877	364,173
Total Liabilities & Equity	332,955	375,839	426,375	494,124	451,494	429,053
Net Cash (Debt)	141,842	201,084	262,252	293,554	271,560	226,526
Net Cash Growth	-41.57%	-23.32%	-10.66%	8.10%	19.88%	33.47%
Net Cash Per Share	15198.63	21546.50	28100.75	31454.72	29098.14	24272.60
Filing Date Shares Outstanding	9.33	9.33	9.33	9.33	9.33	9.33
Total Common Shares Outstanding	9.33	9.33	9.33	9.33	9.33	9.33
Working Capital	213,201	249,208	295,893	374,799	326,425	291,055
Book Value Per Share	27242.04	31032.37	36774.09	45837.52	41668.77	39021.74
Tangible Book Value	252,081	287,397	340,754	425,052	385,886	361,008
Tangible Book Value Per Share	27010.87	30795.08	36512.36	45544.94	41348.27	38682.57
Buildings	32,966	32,966	32,966	32,966	32,966	32,966
Machinery	188,596	190,875	187,316	182,470	181,032	181,629
Construction In Progress	226.1	68.69	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.